Samsung and Nestlé team to develop digital platform for better health

Samsung’s Strategy and Innovation Center has teamed with Nestlé’s Institute of Health Sciences to develop a digital health platform that would give consumers data and advice on nutrition and fitness to improve their health.

The partnership hopes to mix IoT, scientifically validated bio sensors, advanced multi-modal technology, and comprehensive nutritional approach to give consumers digital tools to help manage their health by providing useful recommendations on nutrition, lifestyle and fitness, the companies said.

Samsung and Nestlé provided little detail in announcing the collaboration, but promised to release more information when they begin pilot programs on the platform early next year. Samsung’s ARTIK IoT platform will be part of the new platform.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

“Today, we live in an era of smarter living brought about by the convergence of technology and life science,”  Young Sohn, Samsung’s president and chief strategy officer, said in a statement. “It’s an era where the data from smart sensors and devices in our daily life such as mobile phones, wearables, and smart refrigerators can help us to understand our nutrition and activity and to guide us towards a healthier lifestyle.”

Earlier this year, Medidata ($MDSO), which provides cloud-based solutions for clinical research in life sciences, said it was supporting a clinical trial being conducted by Nestlé. The two-year study, which is being done in China, is looking at the impact of nutrition combined with physical activity on mobility in healthy aging adults with joint discomfort.

- check out the release

Related Articles:
Samsung-backed Sensifree raises $5M to advance biometric sensor tech 
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project

Read more on

Suggested Articles

Antonio Gualberto, M.D., Ph.D., helped found Kura Oncology and ran its R&D as CMO. Now, he’s moving over to fill the same role at H3 Biomedicine.

One day after its Opdivo-paired prospect flopped, Five Prime is farming out some preclinical antibodies to keep its clinical-stage pipeline alive.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.